Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
Year: 2025
Type: article
Study design: Clinical Trial
DOI: 10.1002/cpdd.1594
Authors: Bridget L. Morse, Shobha Bhattachar, Xiaosu Ma, David E. Coutant, Boris Czeskis, Clare Nicoll, Kenneth C. Cassidy
Institution: Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413913503